Search research articles
Contact Us
Filters
Showing results (141-150 of 150) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 150 results.
The Annals of Thoracic Surgery
|
October 1, 1977
Diagnosis of perioperative myocardial infarction after coronary artery bypass
C H Moore, F T Gordon, J A Allums, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 1, 1994
Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease
D L Hemsell, B B Little, S Faro, et al.
Surgery, Gynecology & Obstetrics
|
November 1, 1986
A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy
B B Benigno, J Evrard, S Faro, et al.
American Journal of Surgery
|
May 31, 1988
Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections
R L Sweet, S A Gall, R S Gibbs, et al.
American Journal of Obstetrics and Gynecology
|
March 1, 1997
Oral contraception and the recognition of endometritis
R B Ness, L M Keder, D E Soper, et al.
American Journal of Obstetrics and Gynecology
|
April 17, 2001
Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease
J F Peipert, R B Ness, J Blume, et al.
Sexually Transmitted Diseases
|
April 25, 2001
Douching and endometritis: results from the PID evaluation and clinical health (PEACH) study
R B Ness, D E Soper, R L Holley, et al.
American Journal of Obstetrics and Gynecology
|
August 3, 2001
Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study
R B Ness, D E Soper, R L Holley, et al.
Sexually Transmitted Diseases
|
April 1, 1999
Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis
C H Livengood, D E Soper, K L Sheehan, et al.
Controlled Clinical Trials
|
September 19, 1998
Design of the PID Evaluation and Clinical Health (PEACH) Study
R B Ness, D E Soper, J Peipert, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 150) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 150 results.
The Annals of Thoracic Surgery
|
October 1, 1977
Diagnosis of perioperative myocardial infarction after coronary artery bypass
C H Moore, F T Gordon, J A Allums, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 1, 1994
Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease
D L Hemsell, B B Little, S Faro, et al.
Surgery, Gynecology & Obstetrics
|
November 1, 1986
A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy
B B Benigno, J Evrard, S Faro, et al.
American Journal of Surgery
|
May 31, 1988
Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections
R L Sweet, S A Gall, R S Gibbs, et al.
American Journal of Obstetrics and Gynecology
|
March 1, 1997
Oral contraception and the recognition of endometritis
R B Ness, L M Keder, D E Soper, et al.
American Journal of Obstetrics and Gynecology
|
April 17, 2001
Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease
J F Peipert, R B Ness, J Blume, et al.
Sexually Transmitted Diseases
|
April 25, 2001
Douching and endometritis: results from the PID evaluation and clinical health (PEACH) study
R B Ness, D E Soper, R L Holley, et al.
American Journal of Obstetrics and Gynecology
|
August 3, 2001
Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study
R B Ness, D E Soper, R L Holley, et al.
Sexually Transmitted Diseases
|
April 1, 1999
Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis
C H Livengood, D E Soper, K L Sheehan, et al.
Controlled Clinical Trials
|
September 19, 1998
Design of the PID Evaluation and Clinical Health (PEACH) Study
R B Ness, D E Soper, J Peipert, et al.
Page
of 15